Skip to main content

Animations

MJFF Publications

3261 - 3270 of 8825 Results
Title
Year
  • Year
  • 2017
  • 2018
  • 2024
  • 2025
  • 2020
  • 2018
  • 2011
  • 2016
  • 2021
  • 2008
  • Summary Details
    RESTRICTED
    Title: Erythropoietin and small molecule agonists of the tissue-protective erythropoietin receptor increase FXN expression in neuronal cells in vitro and in Fxn-deficient KIKO mice in vivo
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2017.05.011
    Citation Count: 11
  • Summary Details
    OPEN
    Title: CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of Synaptopathies
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00620
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-024-12554-3
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Distinct AQP4 Alterations in Movement Disorders with Primary Synucleinopathy
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.70023
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Dopamine-mediated improvements in dynamic balance control in Parkinson’s disease
    Journal Name: Gait & Posture
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.gaitpost.2020.08.132
    Citation Count: 10
  • Summary Details
    OPEN
    Title: The Binding of BF-227-Like Benzoxazoles to Human α-Synuclein and Amyloid β Peptide Fibrils
    Journal Name: Molecular Imaging
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1177/1536012118796297
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System Atrophy
    Journal Name: The American Journal of Pathology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ajpath.2011.01.006
    Citation Count: 112
  • Summary Details
    RESTRICTED
    Title: A cognitive fMRI study in non-manifesting LRRK2 and GBA carriers
    Journal Name: Brain Structure and Function
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00429-016-1271-4
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Reconstitution of cargo-induced LC3 lipidation in mammalian selective autophagy
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.abg4922
    Citation Count: 43
  • Summary Details
    RESTRICTED
    Title: Allosteric modulation of mGluR4 as a novel therapeutic direction for the treatment of Parkinson's disease
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1096/fasebj.22.1_supplement.103.2
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.